Optomed: Softening growth prospects
Research Note
2020-10-06
12:01
Redeye sees slower revenue growth ahead and lowers fair value to EUR 7.7 per share. While the company remains fundamentally unchanged, the new reality of digitalisation and social distancing will slow down brand-building and soften camera sales in the months ahead.
GA
Gergana Almquist
Disclosures and disclaimers